| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 48.61M | 50.72M | 61.53M | 94.86M | 84.98M | 51.68M |
| Gross Profit | 3.70M | 4.13M | 5.05M | 8.07M | 7.42M | 5.86M |
| EBITDA | -1.29M | 4.45M | 2.91M | 2.01M | 2.81M | 1.16M |
| Net Income | 1.72M | 3.28M | 1.84M | 935.00K | 1.49M | 232.00K |
Balance Sheet | ||||||
| Total Assets | 29.07M | 31.39M | 28.33M | 29.12M | 29.84M | 32.03M |
| Cash, Cash Equivalents and Short-Term Investments | 23.43M | 23.22M | 18.48M | 16.23M | 10.49M | 19.28M |
| Total Debt | 440.00K | 709.00K | 984.00K | 535.00K | 999.00K | 1.51M |
| Total Liabilities | 5.50M | 7.88M | 8.11M | 10.76M | 12.45M | 16.17M |
| Stockholders Equity | 23.57M | 23.51M | 20.22M | 18.36M | 17.39M | 15.86M |
Cash Flow | ||||||
| Free Cash Flow | 2.28M | 5.19M | 2.45M | 6.40M | -8.21M | 7.28M |
| Operating Cash Flow | 2.35M | 5.24M | 2.55M | 6.41M | -8.17M | 7.81M |
| Investing Cash Flow | 184.00K | 183.00K | -121.00K | -2.35M | -28.00K | -462.00K |
| Financing Cash Flow | -180.00K | -417.00K | -607.00K | -1.36M | -637.00K | -803.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | HK$1.07B | 7.05 | 11.29% | 36.94% | 17.49% | 9.67% | |
72 Outperform | HK$1.97B | 13.11 | ― | ― | -10.48% | 30250.00% | |
66 Neutral | HK$52.80M | 4.70 | 7.43% | ― | -11.47% | 5.00% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | HK$70.95M | -7.88 | ― | ― | ― | ― | |
59 Neutral | HK$33.60M | 15.00 | 3.76% | ― | 50.80% | ― | |
46 Neutral | HK$612.17M | -10.60 | -4.09% | 2.25% | 14.29% | -200.37% |